INDOCO REMEDIES LTD. - 532612 - Shareholding for the Period Ended June 30, 2020
Indoco Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here10-07-2020
10-07-2020
INDOCO REMEDIES LTD. - 532612 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30.06.2020
INDOCO REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2020 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended 30.06.202010-07-2020
INDOCO REMEDIES LTD. - 532612 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Regulation 74(5) of SEBI10-07-2020
INDOCO REMEDIES LTD. - 532612 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- JAYSHANKAR MENONDesignation :- Company Secretary and Compliance Officer10-07-2020
INDOCO REMEDIES LTD. - 532612 - Related Party - Regulation 23(9)
Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (LODR)Regulations, 2015 (Listing Regulations)26-06-2020
INDOCO REMEDIES LTD. - 532612 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for Financial year ended 31.03.202026-06-2020
Buy Indoco Remedies; target of Rs 260: ICICI Direct
ICICI Direct is bullish on Indoco Remedies recommended buy rating on the stock with a target price of Rs 260 in its research report dated June 25, 2020.26-06-2020
Hold Indoco Remedies; target of Rs 219: Prabhudas Lilladher
Prabhudas Lilladher recommended Hold rating on Indoco Remedies with a target price of Rs 219 in its research report dated June 25, 2020.25-06-2020
Earnings Call Transcript - Q4FY20 for Indoco Remedies
Conference Call Transcript with Indoco Remedies Management and Analysts on Q4FY20 and Full Year Earnings Performance and Outlook: Removed at Company's Request24-06-2020